Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Bright Minds Biosciences Inc. (DRUG)

Compare
30.00
+1.81
+(6.42%)
At close: April 9 at 4:00:02 PM EDT
31.69
+1.69
+(5.63%)
After hours: April 9 at 7:01:37 PM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Expense
2,748.42
2,822.77
7,386.41
14,975.09
8,786.20
Operating Income
-2,748.42
-2,822.77
-7,386.41
-14,975.09
-8,786.20
Net Non Operating Interest Income Expense
34.45
30.13
--
--
-18.67
Other Income Expense
1,645.90
-9.31
14.19
10.15
154.10
Pretax Income
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Net Income Common Stockholders
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Diluted NI Available to Com Stockholders
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Basic EPS
-0.20
-0.65
-1.98
-6.06
-4.82
Diluted EPS
-0.20
-0.65
-1.98
-6.06
-4.82
Basic Average Shares
4,890.94
4,310.17
3,719.78
2,470.38
1,794.81
Diluted Average Shares
5,009.92
4,310.17
3,719.78
2,470.38
1,794.81
Total Expenses
2,748.42
2,822.77
7,386.41
14,975.09
8,786.20
Net Income from Continuing & Discontinued Operation
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Normalized Income
-2,713.97
-2,792.63
-7,386.41
-14,975.09
-8,804.86
Interest Income
34.45
30.13
--
--
--
Net Interest Income
34.45
30.13
--
--
-18.67
EBIT
-2,748.42
-2,822.77
-7,386.41
-14,975.09
-8,786.20
EBITDA
-2,671.64
-2,749.41
-7,313.96
-14,969.06
-8,786.20
Reconciled Depreciation
76.78
73.36
72.45
6.04
--
Net Income from Continuing Operation Net Minority Interest
-1,068.07
-2,801.95
-7,372.23
-14,964.94
-8,650.76
Total Unusual Items Excluding Goodwill
1,645.90
-9.31
14.19
10.15
154.10
Total Unusual Items
1,645.90
-9.31
14.19
10.15
154.10
Normalized EBITDA
-4,317.54
-2,740.10
-7,328.15
-14,979.21
-8,940.30
9/30/2021 - 3/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TPST Tempest Therapeutics, Inc.
7.15
+9.87%
 
MNPR Monopar Therapeutics Inc.
32.62
+12.79%
 
JANX Janux Therapeutics, Inc.
26.83
+12.78%
 
GNPX Genprex, Inc.
0.2750
+8.06%
 
WVE Wave Life Sciences Ltd.
6.14
+9.64%
 
EWTX Edgewise Therapeutics, Inc.
12.50
+8.79%
 
ONCO Onconetix, Inc.
0.0636
-6.06%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.89
-1.57%
 
PRTG Portage Biotech Inc.
5.02
+2.45%
 
OCEA Ocean Biomedical, Inc.
0.0470
+19.29%